RxDoctor Payments Data

Matthew Bender, MD

Dermatology · Garden City, IDNPI 1881633162

Payments from drug & device makers

What this record shows

29 manufacturers reported payments, led by UCB, Inc. at 45.0% of the total. 2025 is the largest year on record at $1,501, 3.1 times the $482 reported in 2019.

$3,069in general payments, 2019–2025

Across 77 payments — averaging $39.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$1K
  • Pfizer$313
  • Novartis$157
  • Lilly USA, LLC$124
  • Amgen$116
  • Exact Sciences$100
  • plus $878 from 23 others

What the payments were for

  • Consulting fees$1,30042%
  • Food & beverage$1,76958%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,069 in reported general payments places this provider in the 60th percentile of 52 dermatology providers in Idaho.

See all dermatology providers in Idaho

Medicare billing

Part B allowed, 2024
$108,059
Medicare patients
532
Services billed
1,600

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab39$373,729
Cosentyx Sensoready (2 Pens)Secukinumab28$219,809
Taltz AutoinjectorIxekizumab11$110,440
Fluorouracil15$1,636
Metronidazole21$1,554
Triamcinolone Acetonide125$1,182
Clobetasol Propionate23$1,123
Doxycycline Hyclate20$742
Ketoconazole26$490
Imiquimod11$406
Minocycline Hcl21$371
Nystatin18$353
Dutasteride11$339
Clindamycin Phosphate11$337
Hydrocortisone52$284

Paid to pharmacies, not to this prescriber.

Other dermatology in Garden City

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →